AUPH News and Press, Aurinia Pharmaceuticals Inc From 04/15/24

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for the first quarter of 2024 on Thursday, May 2, 2024, before markets open. Aurinia’s management team will host a conference call/webcast at 8:30 am ...

2024-04-11 15:23:48 ET Summary Vertex Pharmaceuticals is acquiring Alpine Immune Sciences for $4.9 billion, gaining access to povetacicept, a potential treatment for IgA nephropathy and up to seven additional indications. Povetacicept has shown promising results in reducing protei...

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will attend the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place at the Metro Toronto Convention Centre in Toronto from April 16-17, 2024. Aurinia management will host one-on-on...

2024-03-05 15:27:16 ET Summary AUPH's strategic review did not result in an acquisition of the company, nor the company acquiring an asset. AUPH has decided to buy back its own stock and focus on Lupkynis. The buyback could provide support for the stock near-term, although a r...

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that Canadian securities regulators have granted exemptive relief for the Company’s share repurchase program, authorizing the Company to purchase up to 15 percent of its issued and outstanding shares in an...

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that management will be participating in the following upcoming investor conferences during the month of March: TD Cowen’s 44th Annual Health Care Conference taking place March 4 - 6, 2024, at the Ma...

2024-02-18 11:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

A look at the top 10 most actives in the United States SoundHound AI Inc. (SOUN) rose 66.7% to $3.76 on volume of 298,289,429 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 70.5% to $0.1091 on volume of 172,174,410 shares Sientra Inc. (SIEN) rose 89.9% to $0.342 on volume of ...

A look at the top 10 most actives in the United States SoundHound AI Inc. (SOUN) rose 62.5% to $3.665 on volume of 269,509,234 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 64.1% to $0.105 on volume of 159,463,786 shares Sientra Inc. (SIEN) rose 119.4% to $0.395 on volume of...

2024-02-15 15:00:53 ET Summary Aurinia Pharmaceuticals Inc. stock price dropped 25% after underwhelming Q4 and full-year 2023 results. Sales of Lupkynis, indicated for lupus nephritis and the company's only commercial product, have failed to meet expectations. Aurinia has init...